Neoprobe gains regulatory clarity on colorectal cancer detection drug
Cancer diagnostics company Neoprobe (NYSE Amex:NEOP) said it had gained clarity around the chemistry and … Continue reading Neoprobe gains regulatory clarity on colorectal cancer detection drug
0 Comments